Authors:
Bennett, JJ
Tjuvajev, J
Johnson, P
Doubrovin, M
Akhurst, T
Malholtra, S
Hackman, T
Balatoni, J
Finn, R
Larson, SM
Federoff, H
Blasberg, R
Fong, YM
Citation: Jj. Bennett et al., Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer, NAT MED, 7(7), 2001, pp. 861-865
Authors:
Zager, JS
Delman, KA
Malhotra, S
Ebright, MI
Bennett, JJ
Kates, T
Halterman, M
Federoff, H
Fong, YM
Citation: Js. Zager et al., Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer, MOL MED, 7(8), 2001, pp. 561-568
Authors:
Wong, RJ
Patel, SG
Kim, SH
DeMatteo, RP
Malhotra, S
Bennett, JJ
St-Louis, M
Shah, JP
Johnson, PA
Fong, YM
Citation: Rj. Wong et al., Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma, HUM GENE TH, 12(3), 2001, pp. 253-265
Authors:
Petrowsky, H
Roberts, GD
Kooby, DA
Burt, BM
Bennett, JJ
Delman, KA
Stanziale, SF
Delohery, TM
Tong, WP
Federoff, HJ
Fong, YM
Citation: H. Petrowsky et al., Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus, J VIROLOGY, 75(15), 2001, pp. 7050-7058
Authors:
Delman, KA
Bennett, JJ
Zager, JS
Burt, BM
McAuliffe, PF
Petrowsky, H
Kooby, DA
Hawkins, WG
Horsburgh, BC
Johnson, P
Fong, Y
Citation: Ka. Delman et al., Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy, HUM GENE TH, 11(18), 2000, pp. 2465-2472